Cargando…

Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum

BACKGROUND: Since miltefosine monotherapy against visceral leishmaniasis (VL) caused by Leishmania donovani has been discontinued in the Indian subcontinent due to an increase in the number of treatment failures, single dose liposomal amphotericin B is now advocated as a treatment option of choice....

Descripción completa

Detalles Bibliográficos
Autores principales:	Hendrickx, Sarah, Van den Kerkhof, Magali, Mabille, Dorien, Cos, Paul, Delputte, Peter, Maes, Louis, Caljon, Guy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444850/ https://www.ncbi.nlm.nih.gov/pubmed/28505185 http://dx.doi.org/10.1371/journal.pntd.0005620

Ejemplares similares

Immunosuppression of Syrian golden hamsters accelerates relapse but not the emergence of resistance in Leishmania infantum following recurrent miltefosine pressure
por: Hendrickx, S., et al.
Publicado: (2018)

Miltefosine enhances infectivity of a miltefosine-resistant Leishmania infantum strain by attenuating its innate immune recognition
por: Bulté, Dimitri, et al.
Publicado: (2021)

Interferon Alpha Favors Macrophage Infection by Visceral Leishmania Species Through Upregulation of Sialoadhesin Expression
por: Van Bockstal, Lieselotte, et al.
Publicado: (2020)

Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection
por: Van Bockstal, Lieselotte, et al.
Publicado: (2020)

Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes
por: Mondelaers, Annelies, et al.
Publicado: (2016)

Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain
por: Hendrickx, Sarah, et al.
Publicado: (2015)

Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis
por: Van Bockstal, Lieselotte, et al.
Publicado: (2019)

Experimental Selection of Paromomycin Resistance in Leishmania donovani Amastigotes Induces Variable Genomic Polymorphisms
por: Hendrickx, Sarah, et al.
Publicado: (2021)

Phenotypic adaptations of Leishmania donovani to recurrent miltefosine exposure and impact on sand fly infection
por: Hendrickx, Sarah, et al.
Publicado: (2020)

Mitochondrial Proteomics of Antimony and Miltefosine Resistant Leishmania infantum
por: Vincent, Isabel M., et al.
Publicado: (2015)

The effect of the sugar metabolism on Leishmania infantum promastigotes inside the gut of Lutzomyia longipalpis: A sweet relationship?
por: Hendrickx, Sarah, et al.
Publicado: (2022)

New insights with miltefosine unresponsiveness in Brazilian Leishmania infantum isolates
por: Bhattacharya, Arijit, et al.
Publicado: (2018)

Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol
por: Gonçalves, Gustavo, et al.
Publicado: (2021)

Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
por: dos Santos Nogueira, Fabio, et al.
Publicado: (2019)

In-Depth Quantitative Proteomics Characterization of In Vitro Selected Miltefosine Resistance in Leishmania infantum
por: Saboia-Vahia, Leonardo, et al.
Publicado: (2022)

3′Nucleotidase/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine
por: Carnielli, Juliana B.T., et al.
Publicado: (2022)

Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with Leishmania infantum
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2023)

Evaluation of a Possible Synergistic Effect of Meglumine Antimoniate with Paromomycin, Miltefosine or Allopurinol on in Vitro Susceptibility of Leishmania tropica Resistant Isolate
por: REZAEI RIABI, Tahereh, et al.
Publicado: (2013)

Identification of Resistance Determinants for a Promising Antileishmanial Oxaborole Series
por: Van den Kerkhof, Magali, et al.
Publicado: (2021)

Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches
por: Rebello, Karina M., et al.
Publicado: (2019)

A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis
por: Carnielli, Juliana B.T., et al.
Publicado: (2018)

Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance
por: Van den Kerkhof, M., et al.
Publicado: (2020)

In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates
por: Hendrickx, Sarah, et al.
Publicado: (2019)

Resolution of tongue lesions caused by Leishmania infantum in a dog treated with the association miltefosine-allopurinol
por: Foglia Manzillo, Valentina, et al.
Publicado: (2009)

Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism()
por: Vincent, Isabel M., et al.
Publicado: (2013)

Natural Resistance of Leishmania infantum to Miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil
por: Carnielli, Juliana B. T., et al.
Publicado: (2019)

Downregulation of FeSOD-A expression in Leishmania infantum alters trivalent antimony and miltefosine susceptibility
por: Santi, Ana Maria Murta, et al.
Publicado: (2021)

In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series
por: Van den Kerkhof, M., et al.
Publicado: (2018)

Generation of Luciferase-Expressing Leishmania infantum chagasi and Assessment of Miltefosine Efficacy in Infected Hamsters through Bioimaging
por: Reimão, Juliana Q., et al.
Publicado: (2015)

Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis
por: Verrest, Luka, et al.
Publicado: (2023)

4E Interacting Protein as a Potential Novel Drug Target for Nucleoside Analogues in Trypanosoma brucei
por: Mabille, Dorien, et al.
Publicado: (2021)

Experimental Strategies to Explore Drug Action and Resistance in Kinetoplastid Parasites †
por: Van den Kerkhof, Magali, et al.
Publicado: (2020)

Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection Protocol
por: Hendrickx, Sarah, et al.
Publicado: (2012)

Impact of pulmonary African trypanosomes on the immunology and function of the lung
por: Mabille, Dorien, et al.
Publicado: (2022)

In Vitro Susceptibility to Miltefosine of Leishmania infantum (syn. L. chagasi) Isolates from Different Geographical Areas in Brazil
por: Espada, Caroline Ricce, et al.
Publicado: (2021)

Paromomycin Affects Translation and Vesicle-Mediated Trafficking as Revealed by Proteomics of Paromomycin –Susceptible –Resistant Leishmania donovani
por: Chawla, Bhavna, et al.
Publicado: (2011)

Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
por: Rahman, Ridwanur, et al.
Publicado: (2017)

Nucleoside analogues for the treatment of animal trypanosomiasis
por: Mabille, Dorien, et al.
Publicado: (2022)

Atomic resolution snapshot of Leishmania ribosome inhibition by the aminoglycoside paromomycin
por: Shalev-Benami, Moran, et al.
Publicado: (2017)

Optimization and Characterization of a Galleria mellonella Larval Infection Model for Virulence Studies and the Evaluation of Therapeutics Against Streptococcus pneumoniae
por: Cools, Freya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_738dsv4j4oipht008bpo7p3v3t